CPI-1189
CAS No. 183619-38-7
CPI-1189( CPI-1189 | REN-1189 | REN-1654 | REN1189 )
Catalog No. M17393 CAS No. 183619-38-7
REN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
|
10MG | 76 | In Stock |
|
25MG | 155 | In Stock |
|
50MG | 260 | In Stock |
|
100MG | 417 | In Stock |
|
500MG | 888 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI-1189
-
NoteResearch use only, not for human use.
-
Brief DescriptionREN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
-
DescriptionREN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
-
In VitroCell Viability Assay Cell Line:SH-SY5Y oncentration:10, 30, 100, 300 nM Incubation Time:1 h Result:Alleviated OGDR-induced cytotoxicity in a concentration-dependent manner.Apoptosis Analysis Cell Line:SH-SY5Y Concentration:100 nM Incubation Time:1 h Result:Inhibited OGDR-induced caspase-3/-9 activation and ssDNA accumulation.Attenuated OGDR-induced apoptosis activation.
-
In Vivo——
-
SynonymsCPI-1189 | REN-1189 | REN-1654 | REN1189
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number183619-38-7
-
Formula Weight234.3
-
Molecular FormulaC13H18N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (426.82 mM)
-
SMILESCC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C
-
Chemical Name4-acetamido-N-(tert-butyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bjugstad KB,et al. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res. 1998 Jun 8;795(1-2):349-57.
molnova catalog
related products
-
c(Bua-Cpa-Thi-Val-As...
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.
-
P005091
P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with EC50 of 4.2 μM.
-
Guanadrel
Guanadrel is an antihypertensive agent.?